New Cancer Detection Method Using Dogs and AI

Have you ever thought about how dogs, those lovable companions, can be trained to detect diseases like cancer? It’s pretty fascinating. Well, some Israeli startups are now combining these amazing canine abilities with advanced technology to create a revolutionary method in medicine.

One such biotech company is working on home cancer screening tests, integrating the use of dogs in their process. Here’s how it goes: you order a test, receive it at home, then breathe into a special high-tech mask—kind of like an N95—for about three minutes. After that, you send the sample to a Spotitearly lab.

At the lab, specially trained dogs will give your breath sample a thorough sniff. If cancer is present, they’ll be able to detect it.

According to Shlomi Madar, the CEO of Spotitearly, “Our dogs are natural workers and thrive on the challenge of using their sense of smell. Training them to recognize specific odors was, well, rather easy.” He mentions that dogs’ olfactory capabilities are significantly higher—between 10,000 to 100,000 times—than humans, which is why they excel at scent-based tasks.

Madar explains that dogs identify cancer by detecting specific volatile organic compounds (VOCs) that have a unique odor signature.

As remarkable as dog instincts are, the real innovation happens when their capabilities intersect with artificial intelligence. Madar elaborates, “While the dogs are busy sniffing, our proprietary AI platform, Lucid, tracks and analyzes various signals, gathering thousands of data points every second.” This combination allows the system to screen samples in just one second.

The overarching aim here is to catch cancer early when it’s most treatable.

“Often, cancer is diagnosed too late,” Madar notes. “We want to identify malignancies earlier to improve survival rates.” The test is currently in the later stages of development, expected to be available by 2026, and will be priced around $250 for each type of cancer test, with multi-cancer screening discounts planned.

He also mentioned a collaboration with health insurance companies to alleviate costs for patients, emphasizing that making this accessible is a top priority.

In recent clinical studies, Spotitearly’s cancer screening reportedly achieved an accuracy rate of 94%. If successful, this process could spare individuals the hassle of visiting a doctor and going through more invasive procedures.

Madar pointed out, “Many people shy away from regular cancer screenings because they can be uncomfortable. With our method, simply breathing into the mask can lead to more proactive screening habits.” Research indicates that only 14% of cancers in the U.S. are caught through traditional screening, and Spotitearly isn’t looking to replace those tests but rather enhance the overall cancer diagnosis and treatment framework.

When it comes to the dogs, it’s clear they aren’t just lab animals; they are integral to Spotitearly’s team. These pooches work several hours a day, rewarded with treats and affection. In their downtime, they enjoy playing outdoors and getting belly rubs.

And when they hang up their noses for the last time? They often get adopted by their caretakers, ensuring a warm home.

While tackling cancer is the immediate goal, Madar believes this technology could eventually be adapted to detect other serious conditions, like Parkinson’s disease and contagious infections. “We want early diagnosis to become the norm and, in turn, enhance survival rates,” he concluded.